Novartis announces FDA approval for first IL-17A antagonist Cosentyx™ (secukinumab) for moderate-to-severe plaque psoriasis patients
Clorox Healthcare Discusses Proposed AORN/CDC Infection Prevention Recommendation Changes for Preoperative Skin Antisepsis
EnteroMedics Announces FDA Approval of VBLOC® Vagal Blocking Therapy for the Treatment of Obesity
AbbVie Announces U.S. FDA Approval of DUOPA™ (carbidopa and levodopa) Enteral Suspension for the Treatment of Motor Fluctuations in Patients with Advanced Parkinson’s Disease
Kirstie Alley Reveals 50 lb. Weight Loss with Jenny Craig
LYNPARZA™ APPROVED BY THE US FOOD AND DRUG ADMINISTRATION FOR THE TREATMENT OF ADVANCED OVARIAN CANCER IN PATIENTS WITH GERMLINE BRCA-MUTATIONS
Simple, Routine Dental Care Matters for Seniors and the Elderly
Novartis gains FDA approval for Signifor® LAR to treat patients with acromegaly, a rare and life-threatening hormonal disorder
Abbott’s Pioneering, Infectious Disease Testing Platform, IRIDICA, Now Available in Europe
NEW NATIONAL SURVEY REVEALS THE SURPRISING OVERALL LIFE IMPACT OF JOINT PAIN — IT’S MORE THAN PHYSICAL
NATIONAL SURVEY REVEALS CONFLICTED MINDSET OF COLLEGE STUDENTS ABOUT ADHD PRESCRIPTION STIMULANT MISUSE, ABUSE AND DIVERSION
Through Laughter and Tears Comes First–Ever Documentary about Life with PseudoBulbar Affect (PBA)
American Diabetes Association Reveals America’s Healthy Holiday Meal
INTRODUCING VIOLET™ IODINE, NEW ONCE-DAILY, NON-PRESCRIPTION PILL FOR RELIEF OF PREMENSTRUAL BREAST DISCOMFORT*
AMGEN AND ONYX ANNOUNCE DETAILED RESULTS FROM PHASE 3 ASPIRE STUDY OF KYPROLIS®(CARFILZOMIB) IN PATIENTS WITH RELAPSED MULTIPLE MYELOMA
Novartis highlights new CTL019 clinical data showing complete remissions in children and young adults with relapsed/refractory acute lymphoblastic leukemia
Sanofi Receives FDA Approval of Priftin®(rifapentine) Tablets for the Treatment of Latent Tuberculosis Infection
Merck’s HIV Education Campaign, I Design, Reveals Video and Poem Created by the HIV Community in Honor of World AIDS Day
HOCOMA CHANGES THE GAME IN AT-HOME BACK TRAINING WITH INTRODUCTION OF VALEDO®
New National Survey Highlights Importance of Sexual Health but Reveals Lack of Comfort in Addressing Issues
EPILEPSY PATIENTS AND ADVOCATES URGED TO DECK THEIR HALLS WITH PURPLE LIGHTS THIS HOLIDAY SEASON
Pullman Regional Hospital Invests in Bacteria-Killing Copper to Reduce Potentially Deadly Infections
Actavis to Acquire Allergan to Create Top 10 Global Growth Pharmaceutical Company with $23 Billion in Revenue
DC Department of Health Releases New Study: HIV Prevention Campaigns Effective; Contribute to Reduction in HIV Rates
Celiac Disease Center at Columbia University Unveils Video Campaign at 13th Anniversary Gala to Demonstrate the Severity of Celiac Disease for Patients
|
|
The message is clear Multimedia public relations is not just the wave of the future. It’s the reality of today.
|